Nicolas Hubacz: Top Selling Pharmaceuticals of 2023

Nicolas Hubacz shared on LinkedIn:

“Top Selling Pharmaceuticals of 2023.

As the COVID-19 pandemic’s grip lessened in 2023, the pharmaceutical industry once again relied heavily on immunology and oncology driving their sales.

An in-depth examination of financial records by Drug Discovery & Development showed that sales in immunology, oncology, and infectious diseases reached $35.23 billion, $64.41 billion, and $39.95 billion, respectively!

1. Keytruda (pembrolizumab) – Merck
2. Eliquis (apixaban) – Pfizer-Bristol Myers Squibb
3. Ozempic (semaglutide) – Novo Nordisk
4. Humira (adalimumab) – AbbVie
5. Comirnaty (covid19 vaccine) – Pfizer-BioNTech SE
6. Dupixent (dupilumab) by Sanofi – Regeneron
7. Stelara (ustekinumab) – Janssen Inc.
8. Biktarvy (bictegravir, emtricitabine, tenofovir, alafenamide) – Gilead Sciences
9. Imbruvica (ibrutinib) – Janssen Inc.
10. Gardasil (HPV vaccine) – Merck

Credit to Scientome.”

Source: Nicolas Hubacz/LinkedIn